(Q46218711)

20 December 2017

title

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients (English)

1 reference

20 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

2

J O Dostrovsky

1 reference

20 December 2017

William Hutchison

6

object named as

W D Hutchison

1 reference

20 December 2017

Andres Lozano

5

object named as

A M Lozano

1 reference

20 December 2017

author name string

I A Prescott

1

1 reference

20 December 2017

E Moro

3

1 reference

20 December 2017

M Hodaie

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

2 December 2008

1 reference

20 December 2017

published in

Brain

1 reference

20 December 2017

volume

132

1 reference

20 December 2017

issue

Pt 2

1 reference

20 December 2017

page(s)

309-318

1 reference

20 December 2017

L-dopa stimulates the release of [3H]gamma-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Synaptic organisation of the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Dopamine-mediated regulation of corticostriatal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Dendritic release of dopamine in the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Plasticity in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Release of dopamine from dendrites in rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Effects of apomorphine on globus pallidus neurons in parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Dopamine receptors and brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: surgical efficacy and prediction of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Dopamine release in substantia nigra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Levodopa motor complications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Pathophysiology of the basal ganglia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

21 January 2018

Deep brain stimulation

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Blockage of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

The GABA Neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Altered plasticity of the human motor cortex in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN322

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWN322

1 reference

20 December 2017

1 reference

20 December 2017